Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
OPRX 
OPTIMIZERx Corp (OPRX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: OPRX (4-star) is a STRONG-BUY. BUY since 24 days. Simulated Profits (5.67%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $19
1 Year Target Price $19
| 4 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 107.36% | Avg. Invested days 45 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 321.73M USD | Price to earnings Ratio - | 1Y Target Price 19 |
Price to earnings Ratio - | 1Y Target Price 19 | ||
Volume (30-day avg) 7 | Beta 1.2 | 52 Weeks Range 3.78 - 19.25 | Updated Date 09/15/2025 |
52 Weeks Range 3.78 - 19.25 | Updated Date 09/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.54 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.42% | Operating Margin (TTM) 10.92% |
Management Effectiveness
Return on Assets (TTM) 1.33% | Return on Equity (TTM) -8.21% |
Valuation
Trailing PE - | Forward PE 18.62 | Enterprise Value 334122021 | Price to Sales(TTM) 3.07 |
Enterprise Value 334122021 | Price to Sales(TTM) 3.07 | ||
Enterprise Value to Revenue 3.19 | Enterprise Value to EBITDA 321.89 | Shares Outstanding 18565000 | Shares Floating 14319210 |
Shares Outstanding 18565000 | Shares Floating 14319210 | ||
Percent Insiders 15.12 | Percent Institutions 71.14 |
Upturn AI SWOT
OPTIMIZERx Corp
Company Overview
History and Background
OPTIMIZERx Corp was founded in 2006. It provides digital health solutions for pharmaceutical manufacturers and healthcare providers, focusing on patient access and adherence.
Core Business Areas
- Therapeutic Support Program (TSP) Solutions: Provides digital programs and technology to support patients on specific therapies, improving adherence and outcomes.
- Financial Messaging Solutions: Enables pharmaceutical companies to digitally communicate cost savings opportunities to healthcare providers.
- Data Analytics: Offers insights into patient behavior and treatment patterns to optimize pharmaceutical marketing and sales strategies.
Leadership and Structure
OPTIMIZERx is led by CEO Bryan Berberian. The company has a typical corporate structure with departments like sales, marketing, technology, and finance.
Top Products and Market Share
Key Offerings
- eCoupon Program: Facilitates electronic coupons and discount programs for medications. Market share information is not publicly available. Competitors include ConnectiveRx and RxSense.
- Therapeutic Adherence Programs: Digital programs designed to improve patient compliance with prescribed medications. Market share information is not publicly available. Competitors include Wellframe and Twistle.
Market Dynamics
Industry Overview
The pharmaceutical digital health market is growing due to the increasing need for patient engagement and cost-effective healthcare solutions.
Positioning
OPTIMIZERx is positioned as a provider of solutions that improve patient access and adherence, with a focus on digital communication and data analytics.
Total Addressable Market (TAM)
The TAM for digital pharmaceutical marketing and patient adherence solutions is estimated to be in the billions of dollars. OPTIMIZERx is capturing a small portion of this TAM.
Upturn SWOT Analysis
Strengths
- Established relationships with pharmaceutical manufacturers
- Proprietary technology platform
- Strong focus on patient adherence
Weaknesses
- Dependence on pharmaceutical industry spending
- Limited geographic diversification
- Smaller scale compared to major competitors
Opportunities
- Expansion into new therapeutic areas
- Increased adoption of digital health solutions
- Strategic partnerships with healthcare providers
Threats
- Increased competition from larger players
- Changes in healthcare regulations
- Economic downturn affecting pharmaceutical spending
Competitors and Market Share
Key Competitors
- CVS (CVS)
- AMN Healthcare Services (AMN)
- McKesson (MCK)
Competitive Landscape
OPTIMIZERx faces competition from larger companies with more resources. Its advantages lie in its specialized focus on digital health solutions for the pharmaceutical industry.
Growth Trajectory and Initiatives
Historical Growth: Historical growth patterns cannot be determined without historical financial data.
Future Projections: Future projections unavailable in the current context.
Recent Initiatives: Recent initiatives information not available in the current context.
Summary
OPTIMIZERx is a niche player in the pharmaceutical digital health space, focusing on patient access and adherence solutions. While its specialized focus is a strength, it faces challenges from larger, more diversified competitors. The company's success depends on its ability to innovate and expand its product offerings.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on limited publicly available information and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OPTIMIZERx Corp
Exchange NASDAQ | Headquaters Waltham, MA, United States | ||
IPO Launch date 1996-10-22 | President & CEO Mr. Stephen L. Silvestro | ||
Sector Healthcare | Industry Health Information Services | Full time employees 128 | Website https://www.optimizerx.com |
Full time employees 128 | Website https://www.optimizerx.com | ||
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.